Validation of the BCIS-1 Myocardial Jeopardy score using cardiac magnetic resonance perfusion imaging

Summary The recently described angiographic BCIS‐1 Myocardial Jeopardy Score (BCIS‐JS) provides a semi‐quantitative estimate of the extent of coronary artery disease (CAD). It is simple to use and applicable to all patients including those with bypass grafts. Our objective was to validate the BCIS‐J...

Full description

Saved in:
Bibliographic Details
Published inClinical physiology and functional imaging Vol. 33; no. 2; pp. 101 - 108
Main Authors Morton, Geraint D. J., De Silva, Kalpa, Ishida, Masaki, Chiribiri, Amedeo, Indermuehle, Andreas, Schuster, Andreas, Redwood, Simon, Nagel, Eike, Perera, Divaka
Format Journal Article
LanguageEnglish
Published England Blackwell Publishing Ltd 01.03.2013
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Summary The recently described angiographic BCIS‐1 Myocardial Jeopardy Score (BCIS‐JS) provides a semi‐quantitative estimate of the extent of coronary artery disease (CAD). It is simple to use and applicable to all patients including those with bypass grafts. Our objective was to validate the BCIS‐JS by evaluating its correlation with myocardial ischaemic burden and its accuracy at predicting a prognostic ischaemic threshold. Seventy‐five patients with angina and known or suspected CAD referred for coronary angiography prospectively underwent high‐resolution CMR perfusion imaging. There was good correlation between the BCIS‐JS and myocardial ischaemic burden: r = 0·75, P<0·0001. Area under the ROC curve for BCIS‐JS to detect ≥12% myocardial ischaemic burden was 0·87 (95% CI 0·78–0·96). BCIS‐JS ≥6 predicted ≥12% myocardial ischaemic burden with a sensitivity of 68% and a specificity of 91%. The BCIS‐JS correlates well with myocardial ischaemic burden. A BCIS‐JS ≥6 predicts the prognostically important ischaemic threshold of 12% with high specificity. These findings demonstrate that the BCIS‐JS has functional relevance and support its utility for classification of CAD burden in clinical trials and in clinical practice.
Bibliography:European Union Grant - No. 224495
ark:/67375/WNG-BKK6KFZ5-F
Biomedical Research Centre - No. RE/08/003
istex:DA3B02A78101A475F1BA87A3E9A3B7AB36A3F813
British Heart Foundation - No. BRC-CTF 196; No. RE/08/003
ArticleID:CPF1167
Heart Research UK - No. RG2593/10/12 KDS; No. RE/08/003
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Undefined-1
ObjectType-Feature-3
content type line 23
ObjectType-Feature-1
ObjectType-Article-1
ObjectType-Feature-2
ISSN:1475-0961
1475-097X
DOI:10.1111/j.1475-097X.2012.01167.x